Vericor selects Parker Aerospace’s fuel atomization nozzle for TF50F
Category: #business  By Mateen Dalal  Date: 2019-06-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

Vericor selects Parker Aerospace’s fuel atomization nozzle for TF50F

Parker Aerospace, a business division of Parker Hannifin Corporation, one of the leaders in motion & control technologies, recently announced that its PowerGen division (Gas Turbine Fuel Systems) was awarded the fuel atomization nozzle & dual fuel classified assembly for TF50F, oil field gas turbine of Vericor Power system, cite sources.

Reportedly, additive manufacturing & electron-beam manufacturing methods will be used to design the new fuel nozzle, and this will enable designed features to provide cleaner fuel burn along with reducing part count & improving manufacturing predictability. The control of fuel droplet size & fuel atomization is important for efficient turbine engine combustion.

As per sources close to the matter, PowerGen Division of Gas Turbine Fuel Systems is leveraging its extensive engineering expertise in both aerospace & land-based gas turbine fuel nozzle design to develop the novel fuel atomization nozzle and manifold assembly. The PowerGen Division has been closely working with Additive Manufacturing Learning & Development center of Parker Hannifin corporation. Parker’s wide-ranging resources were employed to bring the company’s engineered solutions to market using additive manufacturing methods.

The newly designed fuel nozzle will take advantage of additive manufacturing techniques for improving fuel flow within the nozzle, leading to better fuel atomization & distribution within combustion chamber of the engine, enhancing combustion performance, providing improved fuel efficiency, hence reducing emissions. Additionally, additive manufacturing will enable the new TF50F fuel nozzle to be manufactured using fewer parts than traditionally manufactured nozzles, with a 30% part-count reduction.

Steve O’Connor, GM, Gas Turbine Fuel Systems, PowerGen Division, was reported to say that Parker’s use of additive manufacturing and its fuel atomization expertise will maximize value for Vericor. In partnership with Vericor, PowerGen team has devised the best way to design & build fuel nozzles for the TF50F gas turbine.

Testing and verification of new fuel nozzles is complete and the manufacturing is underway to support delivery by third quarter of 2019, O’Connor added.

Source credits: https://www.businesswire.com/news/home/20190616005043/en/Parker-Aerospace-Fuel-Atomization-Nozzles-Selected-Vericor

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZenecas Farxiga gets fast track status to treat heart failure
AstraZenecas Farxiga gets fast track status to treat heart failure
By Mateen Dalal

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Upstream Works, Aceyus to pioneer customer experience solutions
Upstream Works, Aceyus to pioneer customer experience solutions
By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
By Mateen Dalal

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...